TR200601608T1 - Long-acting compositions comprising an avermectin combination. - Google Patents
Long-acting compositions comprising an avermectin combination.Info
- Publication number
- TR200601608T1 TR200601608T1 TR2006/01608T TR200601608T TR200601608T1 TR 200601608 T1 TR200601608 T1 TR 200601608T1 TR 2006/01608 T TR2006/01608 T TR 2006/01608T TR 200601608 T TR200601608 T TR 200601608T TR 200601608 T1 TR200601608 T1 TR 200601608T1
- Authority
- TR
- Turkey
- Prior art keywords
- combination
- long
- avermectin
- acting compositions
- ivermectin
- Prior art date
Links
- 239000005660 Abamectin Substances 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 2
- RRZXIRBKKLTSOM-XPNPUAGNSA-N avermectin B1a Chemical compound C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 RRZXIRBKKLTSOM-XPNPUAGNSA-N 0.000 title 1
- AZSNMRSAGSSBNP-UHFFFAOYSA-N 22,23-dihydroavermectin B1a Natural products C1CC(C)C(C(C)CC)OC21OC(CC=C(C)C(OC1OC(C)C(OC3OC(C)C(O)C(OC)C3)C(OC)C1)C(C)C=CC=C1C3(C(C(=O)O4)C=C(C)C(O)C3OC1)O)CC4C2 AZSNMRSAGSSBNP-UHFFFAOYSA-N 0.000 abstract 3
- IBSREHMXUMOFBB-JFUDTMANSA-N 5u8924t11h Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O3)C=C[C@H](C)[C@@H](C(C)C)O4)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 IBSREHMXUMOFBB-JFUDTMANSA-N 0.000 abstract 3
- SPBDXSGPUHCETR-JFUDTMANSA-N 8883yp2r6d Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O[C@@H]([C@@H](C)CC4)C(C)C)O3)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1C[C@H](C)[C@@H]([C@@H](C)CC)O[C@@]21O[C@H](C\C=C(C)\[C@@H](O[C@@H]1O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C1)[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\1)O)C[C@H]4C2 SPBDXSGPUHCETR-JFUDTMANSA-N 0.000 abstract 3
- 229950008167 abamectin Drugs 0.000 abstract 3
- 229960002418 ivermectin Drugs 0.000 abstract 3
- 241001465754 Metazoa Species 0.000 abstract 1
- 244000045947 parasite Species 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicinal Preparation (AREA)
Abstract
Hayvanlardaki parazitleri kontrol altına almak için, yavaş sahnımlı bir araç içinde bir ivermektin ve abamektin kombinasyonu içeren uzun süre etkili bir bileşim olup, burada ivermektin ve abamektinina/h cinsinden toplam yüzdesi a/h %3 veya daha yüksektir ve ivermektin konsantrasyonu abamektin konsantrasyonundan daha yüksektir.A long-acting composition containing a combination of ivermectin and abamectin in a slow-stage vehicle to control parasites in animals, where the total percentage w / h in ivermectin and abamectin is 3% or higher and the concentration of ivermectin is higher than the concentration of abamectin.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03078280 | 2003-10-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR200601608T1 true TR200601608T1 (en) | 2006-12-21 |
Family
ID=34442985
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2006/01608T TR200601608T1 (en) | 2003-10-17 | 2004-10-15 | Long-acting compositions comprising an avermectin combination. |
Country Status (7)
| Country | Link |
|---|---|
| CN (1) | CN1867341B (en) |
| AU (1) | AU2004281551B2 (en) |
| BR (1) | BRPI0415366A (en) |
| NZ (1) | NZ546340A (en) |
| TR (1) | TR200601608T1 (en) |
| WO (1) | WO2005037294A1 (en) |
| ZA (1) | ZA200603931B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1849363A1 (en) * | 2006-03-09 | 2007-10-31 | Cheminova A/S | Synergistic combination of glutamate- and GABA-gated chloride agonist pesticide and at least one of Vitamin E or Niacin |
| NZ590141A (en) * | 2008-06-24 | 2012-05-25 | Merial Ltd | Anthelminthic formulations including castor oil and another vegetable oil |
| AU2013201479C1 (en) | 2012-03-13 | 2017-11-09 | Elanco New Zealand | Long Acting Compositions |
| CN104430394A (en) * | 2014-10-20 | 2015-03-25 | 广西大学 | Preparation method of ivermectin/emamectin benzoate compound microcapsule suspension |
| CN109329077A (en) * | 2018-09-27 | 2019-02-15 | 江苏省协同医药生物工程有限责任公司 | A kind of anti parasitic experimental animal padding and preparation method thereof |
| CN110721152B (en) * | 2018-12-29 | 2022-01-14 | 瑞普（天津）生物药业有限公司 | Sustained-release composition for treating animal skin parasite and fungus infection |
| WO2025024908A1 (en) * | 2023-07-28 | 2025-02-06 | Elanco Saude Animal Ltda | Antiparasitic compositions of macrocyclic lactones |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8813353D0 (en) * | 1988-06-06 | 1988-07-13 | Ici Plc | Therapeutic product |
| CN1375293A (en) * | 2001-03-16 | 2002-10-23 | 王玉万 | Mixed vermifuge injection containing iodo-ether salicylamine |
| BR0104761A (en) * | 2001-08-08 | 2003-08-12 | Inst De Pesquisa Em Saude Anim | Abamectin plus ivermectin combination for use as endectocide in cattle |
-
2004
- 2004-10-15 BR BRPI0415366-9A patent/BRPI0415366A/en not_active Application Discontinuation
- 2004-10-15 WO PCT/EP2004/052554 patent/WO2005037294A1/en not_active Ceased
- 2004-10-15 AU AU2004281551A patent/AU2004281551B2/en not_active Expired
- 2004-10-15 NZ NZ546340A patent/NZ546340A/en not_active IP Right Cessation
- 2004-10-15 TR TR2006/01608T patent/TR200601608T1/en unknown
- 2004-10-15 CN CN2004800305841A patent/CN1867341B/en not_active Expired - Lifetime
-
2006
- 2006-05-16 ZA ZA200603931A patent/ZA200603931B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1867341B (en) | 2010-06-16 |
| AU2004281551A1 (en) | 2005-04-28 |
| AU2004281551B2 (en) | 2009-10-29 |
| ZA200603931B (en) | 2007-09-26 |
| WO2005037294A1 (en) | 2005-04-28 |
| CN1867341A (en) | 2006-11-22 |
| BRPI0415366A (en) | 2006-12-12 |
| NZ546340A (en) | 2009-08-28 |
| WO2005037294A8 (en) | 2005-07-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0317696B8 (en) | whitening composition | |
| DE60220174D1 (en) | HERBICIDAL COMPOSITIONS INCLUDING IMIDAZOLINONIC ACID | |
| BRPI0518406A2 (en) | compositions having high antiviral and antibacterial efficacy | |
| FR14C0054I1 (en) | C-ARYL GLUCOSIDES AS SGLT-2 INHIBITORS AND RELATED METHOD | |
| WO2004001019A3 (en) | Novel nanoparticles and use thereof | |
| SE0102315D0 (en) | Compounds | |
| MA28976B1 (en) | IMMUNOSTIMULATORY OLIGONUCLEOTIDE MULTIMERS | |
| EP1685845A4 (en) | Sialogogue and, containing the same, oral composition and food composition | |
| BR0207585A (en) | Method for improving an animal's growth performance, growth promoting composition, and construction for the in vivo release of an effective amount of cytokine. | |
| MXPA04006210A (en) | Aqueous compositions containing metronidazole. | |
| EP1476121A4 (en) | TOPICAL COMPOSITION OF IVERMECTIN | |
| EP1701731A4 (en) | GLP-1 (9-36): METHODS AND COMPOSITIONS | |
| ATE396697T1 (en) | HAIR TREATMENT COMPOSITION CONTAINING SUGAR LACTONE | |
| BRPI0418378A (en) | combinations of active substances with insecticidal properties | |
| TR200401120T4 (en) | Endoparasiticidal gel composition | |
| BR0304298A (en) | Composition containing a cosmetically active organic acid and a vegetable product | |
| WO2005053421A3 (en) | Palatability enhanced composition and method for animal consumption | |
| TR200601608T1 (en) | Long-acting compositions comprising an avermectin combination. | |
| AR046120A1 (en) | FUNGICIDATE FOMULATIONS CONTAINING COPPER | |
| HUP0400520A2 (en) | Dermatological formulations containing clindamycin and a zinc-salt | |
| UA97346C2 (en) | Stable emulsion composition | |
| WO2004039326A3 (en) | Propofol with cysteine | |
| BRPI0403461A (en) | stabilized compositions containing an oxygen-labile active agent | |
| DE60327253D1 (en) | FOOD COMPOSITION CONTAINING L (+) - MILKY ACID | |
| DE602004014787D1 (en) | ANTI-TUMORAL FORMULATIONS WITH DEFIBROTIDE ALONE OR IN COMBINATION WITH OTHER ANTITUMOROUS AGENTS |